Related Experiment Videos
Platelets: cell proliferation and atherosclerosis
Abstract:
Intimal smooth muscle proliferation is the hallmark of the lesions of atherosclerosis. Endothelial injury is postulated to precede this intimal smooth muscle proliferative response, which is mediated by a potent mitogenic factor derived from adherence, aggregation, and release by platelets at sites of endothelial injury. Smooth muscle proliferation is accompanied by varying amounts of connective tissue formation and intracellular and extracellular lipid deposition, dependent upon the risk factors encountered in each patient. The platelet-derived mitogen (PF) is a stable, cationic, relatively low molecular weight (10,000-30,000) protein that has been partially purified by ion exchange chromotography and gel filtration. Less than 100 ng of PF/ml culture medium can stimulate sparse 3T3 cells or smooth muscle cells, but not endothelial cells, to undergo multiple cell divisions in the presence of 5% cell-free, plasma-derived serum. The latter contains no mitogenic activity. The interaction of the platelet mitogen and plasma-derived components, including lipoproteins, plays a critical role in smooth muscle proliferation in vitro and in vivo in the induction of the lesions of atherosclerosis.
Insights
Platelets release a potent mitogen that drives smooth muscle cell proliferation, a key factor in atherosclerosis. This platelet-derived factor, interacting with lipoproteins, contributes to lesion development.
Area of Science:
- Cardiovascular Biology
- Cellular and Molecular Medicine
- Atherosclerosis Research
Background:
- Intimal smooth muscle proliferation is a defining characteristic of atherosclerotic lesions.
- Endothelial injury is hypothesized to initiate this proliferative response.
- Platelets are implicated in releasing mitogenic factors at sites of injury.
Purpose of the Study:
- To investigate the role of platelet-derived factors in smooth muscle cell proliferation.
- To characterize the properties of the platelet-derived mitogen.
- To understand the interaction of platelet mitogens with plasma components in atherosclerosis.
Main Methods:
- Partial purification of platelet-derived mitogen (PF) using ion exchange chromatography and gel filtration.
- In vitro cell culture experiments stimulating 3T3 and smooth muscle cells with PF.
- Assessment of mitogenic activity in cell-free, plasma-derived serum.
Main Results:
- Platelet-derived mitogen (PF) is a stable, cationic protein (10-30 kDa).
- PF stimulates multiple cell divisions in sparse 3T3 and smooth muscle cells at low concentrations (ng/ml).
- Endothelial cells do not respond mitogenically to PF; plasma-derived serum alone lacks mitogenic activity.
Conclusions:
- Platelet-derived mitogen plays a critical role in smooth muscle proliferation.
- The interaction between PF and plasma components, including lipoproteins, is crucial for in vitro and in vivo atherosclerosis induction.
- Understanding this pathway offers insights into atherosclerotic lesion development.